16 results
Management of Diabetes Mellitus in Patients With CKD

1. Monitor for changes in BP, serum creatinine, &
Continue ACEi or ... ADA/KDIGO Consensus ... evidence-based pharmacologic ... ADA #KDIGO #eGFR ... #Insulin #metformin
Insulin Dosing Basics - Initiating Insulin for T2DM and Converting Insulin Products 

Insulin dosing can be
Insulin Dosing Basics ... For type 2 diabetes ... for type 2 diabetes ... run into patient cases ... #Prescribing #Pharmacology
Estimating the Total Daily Dose (TDD) of Insulin: Weight-Based Dosing
TDD in units of insulin = N
including most type 1 diabetics ... including most 2 diabetics ... Add sliding scale ... Weight #Based #pharmacology ... endocrinology #diabetes
Diabetes Mellitus Type 2 Inpatient Medication Guide

Classes: Biguanide, Sulfonylurea, TZD, DPP-4 inhibitor, GLP-1 receptor agonist, SGLT2i,
Diabetes Mellitus ... Medication Guide Classes ... in Type 1 Diabetes ... monitors in Type 1 Diabetes ... #Medications #pharmacology
Effects on body weight of various classes of type-2 diabetes medications.
 - Metformin - Weight Loss
weight of various classes ... of type-2 diabetes ... Weight Gain ++ - Insulin ... Weight Gain ++++ #diabetes ... weightgain #comparison #pharmacology
Insulin Calculations for Type 1 Diabetes 

Insulin-to-Carb Ratio (ICR) 500/TDD = #g of carbs covered by
for Type 1 Diabetes ... patients with type 1 diabetes ... They will also add ... SensitivityFactor #Type1 #Diabetes ... #DM1 #Pharmacology
Ketosis Disorders
Ketone bodies are a normal metabolic energy source. Excessive unregulated production of ketones, often accompanied
ketoacidosis (AKA ... • Diabetic ketoacidosis ... (DKA) - caused ... by complete insulin ... Glucosuria causes
SNRls (Serotonin/Norepinephrine Reuptake Inhibitors) - FDA Approved Indications 

Venlafaxine (Effexor) - GAD, MDD, Panic Disorder, SAD
Inhibitors) - FDA ... Cymbalta) - GAD, MDD, Diabetic ... #Indications #Pharmacology ... #Psychiatry #FDA
Metformin Pharmacology Summary
Mechanisms of Action:
 • Suppresses gluconeogenesis by the liver
 • Increases insulin-mediated glucose utilization
Metformin Pharmacology ... • Increases insulin-mediated ... agent • Does not cause ... #Metformin #Pharmacology ... #Summary #DM2 #diabetes
GLP-1 Receptor Agonists - Pharmacology Summary
Mechanisms of Action: Stimulate glucose-dependent insulin release from the pancreas (GLP-1
Receptor Agonists - Pharmacology ... glucose-dependent insulin ... not definitively cause ... Receptor #Agonists #Pharmacology ... #Summary #DM2 #diabetes